AU2001286303A1 - Recombinant fusion protein for diagnosis of tsutsugamushi disease - Google Patents

Recombinant fusion protein for diagnosis of tsutsugamushi disease

Info

Publication number
AU2001286303A1
AU2001286303A1 AU2001286303A AU8630301A AU2001286303A1 AU 2001286303 A1 AU2001286303 A1 AU 2001286303A1 AU 2001286303 A AU2001286303 A AU 2001286303A AU 8630301 A AU8630301 A AU 8630301A AU 2001286303 A1 AU2001286303 A1 AU 2001286303A1
Authority
AU
Australia
Prior art keywords
diagnosis
fusion protein
recombinant fusion
tsutsugamushi disease
tsutsugamushi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286303A
Inventor
Ik Sang Kim
Seung Yong Seong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Pharmaceutical Co Ltd
Original Assignee
Pacific Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Pharmaceutical Co Ltd filed Critical Pacific Pharmaceutical Co Ltd
Publication of AU2001286303A1 publication Critical patent/AU2001286303A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001286303A 2000-09-08 2001-09-07 Recombinant fusion protein for diagnosis of tsutsugamushi disease Abandoned AU2001286303A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR0053269 2000-09-08
KR1020000053269A KR20020020281A (en) 2000-09-08 2000-09-08 Gene recombinant protein for diagnosis of tsutsugamushi disease
PCT/KR2001/001516 WO2002020611A1 (en) 2000-09-08 2001-09-07 Recombinant fusion protein for diagnosis of tsutsugamushi disease

Publications (1)

Publication Number Publication Date
AU2001286303A1 true AU2001286303A1 (en) 2002-03-22

Family

ID=19688088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286303A Abandoned AU2001286303A1 (en) 2000-09-08 2001-09-07 Recombinant fusion protein for diagnosis of tsutsugamushi disease

Country Status (5)

Country Link
JP (1) JP2004508034A (en)
KR (1) KR20020020281A (en)
CN (1) CN1262565C (en)
AU (1) AU2001286303A1 (en)
WO (1) WO2002020611A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020020281A (en) * 2000-09-08 2002-03-15 김익상 Gene recombinant protein for diagnosis of tsutsugamushi disease
KR100796772B1 (en) * 2006-09-04 2008-01-22 주식회사 이뮨메드 Diagonstic formulation for tsutsugamushi disease
CN102027020A (en) 2008-05-16 2011-04-20 海军部长代表的美国政府 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
CN103816349B (en) * 2014-02-24 2016-09-14 葛光霞 A kind of instant particles as Chinese medicine treating extreme noxious heat scrub typhus
WO2016068613A1 (en) * 2014-10-29 2016-05-06 인하대학교 산학협력단 Immune composition for scrub typhus and method for preparing same
KR20170062742A (en) * 2015-11-30 2017-06-08 주식회사 이뮨메드 Diagnostic kit for tsutsugamushi disease
KR102027809B1 (en) * 2016-12-21 2019-11-04 서울대학교산학협력단 Novel Recombinant Protein Antigens of Orientia tsutsugamushi and the Vaccine Composition Using the Same
CN113292641A (en) * 2021-07-15 2021-08-24 李家斌 Method for induced expression and large-scale purification of TSA protein of Oriental tsutsugamushi disease
CN113307852A (en) * 2021-07-15 2021-08-27 李家斌 Induced expression and purification method for 47kDa protein of orientia tsutsutsugamushi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482415B1 (en) * 1997-12-24 2002-11-19 The United States Of America As Represented By The Secretary Of The Navy Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines
KR20020020281A (en) * 2000-09-08 2002-03-15 김익상 Gene recombinant protein for diagnosis of tsutsugamushi disease

Also Published As

Publication number Publication date
JP2004508034A (en) 2004-03-18
CN1262565C (en) 2006-07-05
KR20020020281A (en) 2002-03-15
CN1452635A (en) 2003-10-29
WO2002020611A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2002223640A1 (en) Fusion proteins as immunization treatments of alzheimer's disease
AU2001274809A1 (en) Albumin fusion proteins
AU2002320013A1 (en) Human secreted proteins
AU2002364586A8 (en) Albumin fusion proteins
IL166343A0 (en) Igg fc/hiv-gp 120/c3d fusion protein
AU2002309513A1 (en) Human secreted proteins
HUP0402496A3 (en) Growth hormone fusion protein
AU2002237195A1 (en) Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
AU2001286303A1 (en) Recombinant fusion protein for diagnosis of tsutsugamushi disease
AU2002232596A1 (en) Secreted human proteins
AU2002232803A1 (en) Expression system for recombinant proteins
AU2002251972A1 (en) Fusion proteins based upon somatostatin receptors
AU6604901A (en) Regulation of human hm74-like g protein coupled receptor
AU2002224555A1 (en) Process for producing recombinant protein
AU7709000A (en) Methods for producing recombinant proteins
AU4483500A (en) Human membrane-associated proteins
AU2452301A (en) Protein methylarginine-specific antibodies
AU2001244647A1 (en) Process for producing recombinant protein
AU2002311620A1 (en) Methods of making and using expression constructs for the expression of recombinant proteins
AU2002361963A1 (en) Fusion proteins containing tlp peptides
AU2002219974A1 (en) Immunoglobulin superfamily proteins
AU2003226907A1 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU2659799A (en) Human receptor proteins
AU2173799A (en) Expression of fusion proteins
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence